ECL and MAC Event | The potential for academic development of medicines in Europe
29 March 2023, 15:00-16:30 CET, Online
EVENT AGENDA

Both medical and technological developments have led to the increased provision of cancer medicines on the market, making it possible for cancer patients to live longer with a better quality of life. However, currently, the only way to bring innovative therapies to patients is via a commercial route, with extremely high prices.

With this event, we shine a light on the role that academia can play in the development and availability of innovative cell and gene therapies. Panellists representing the European Commission, the European Medicines Agency, researchers, and patients engage in a discussion on the main bottlenecks that hinder such academic development of medicines and how to overcome them.

Read the ECL recommendations for the academic development in medicines in Europe.